By Investigative Desk
November 2026
A series of explosive investigations published throughout November 2026 has unveiled a systemic failure in the United States’ public health infrastructure, revealing that high-ranking officials at the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) knowingly maintained a compromised vaccine safety monitoring system while silencing internal dissent. Documents obtained through Freedom of Information Law (FOIL) requests and U.S. Senate subpoenas paint a troubling picture of a federal apparatus that prioritized "vaccine confidence" over the rigorous, transparent surveillance of mRNA COVID-19 vaccine side effects.
The findings, corroborated by investigative work from The BMJ, attorney Jimmy Wagner, and independent Senate inquiries, suggest that from as early as October 2020 through July 2024, officials were aware that their primary safety detection algorithm was mathematically incapable of flagging common adverse events. Despite these known limitations, agency leaders continued to cite the lack of "safety signals" as empirical evidence of the vaccines’ absolute safety profile.
The Mathematical Blind Spot: Why the Algorithm Failed
At the heart of the controversy lies the FDA’s "empirical Bayesian" data mining algorithm, a tool designed to flag statistically significant clusters of adverse events within the Vaccine Adverse Event Reporting System (VAERS). Under normal circumstances, this system is intended to act as an early-warning radar. However, during the massive rollout of the mRNA vaccines, the system encountered a "masking" phenomenon that rendered it functionally useless.
Because COVID-19 vaccines accounted for more than 90% of all VAERS reports during the initial rollout, the sheer volume of data skewed the baseline metrics. When both Pfizer and Moderna products elevated risks equally, the "observed" frequency of adverse events matched the "expected" frequency, resulting in a mathematical dead zone. The algorithm essentially treated widespread, vaccine-induced injuries—such as myocarditis, pericarditis, Bell’s palsy, and tinnitus—as part of the background "noise" of the population, thereby triggering zero automated alerts.
Dr. Ana Szarfman, a seasoned FDA medical officer with decades of experience in pharmacovigilance, identified this flaw early in 2021. She collaborated with renowned statistician William DuMouchel to develop an updated, corrective algorithm capable of cutting through the statistical noise to reveal true safety signals. When Dr. Szarfman brought these findings and the proposed solution to her superiors, she was not met with curiosity or gratitude, but with an order to "cease and desist."
Chronology of Suppression: From Warning to Silence
The timeline of internal awareness and subsequent suppression reveals a conscious effort to maintain the status quo:
- October 2020: Implementation of the flawed Bayesian algorithm begins.
- February 2021: Dr. Ana Szarfman warns FDA leadership of the "masking" problem and proposes a corrective algorithm. Her efforts are stifled.
- May 2021: CDC Director Rochelle Walensky publicly states that the agency has "not seen a signal" for myocarditis. Internal emails show that CDC Deputy Director Tom Shimabukuro admits to being "perplexed" that the system is not alerting, even as the agency continues to tell the public the risk is "extremely rare."
- December 2021: Tensions peak within the National Association of Medical Examiners. When professionals raise concerns about cardiac events in young athletes, they are met with accusations of spreading "misinformation."
- 2022: The CDC finally performs Proportional Reporting Ratio (PRR) analyses. The data shows hundreds of adverse events meeting signal criteria for myocarditis and other conditions across 13 consecutive weekly reports. The FDA’s primary Bayesian algorithm, however, triggers nothing.
- October 2023: The FDA’s pharmacovigilance chief sends an internal email admitting that the agency was aware of the algorithm’s fundamental limitations "before and during the pandemic."
Medical Examiners: Private Doubts vs. Public Narratives
While federal agencies were failing to flag signals, the nation’s frontline medical examiners were encountering the reality of these adverse events in the morgue. Private emails obtained via FOIL requests reveal a stark contrast between the internal discourse among forensic pathologists and the official government narrative.
On June 26, 2021, Dr. James Gill, the Chief Medical Examiner of Connecticut, reached out to a national forensic pathology group with a chilling query. He was investigating the death of a 16-year-old boy who had been found dead in his bed just four days after receiving his second dose of the Pfizer vaccine. Dr. Gill noted that the boy’s heart showed "striking ischemic changes."
Similarly, in early June 2021, New York City Chief Medical Examiner Barbara Sampson consulted with Harvard-affiliated pathologists regarding a case of focal lymphocytic myocarditis in a patient who died two months post-vaccination. While Dr. Sampson wrote that she "doubt[ed] there is an association," her reaching out to experts suggests a level of uncertainty that was entirely absent from the public statements issued by the CDC and FDA at the time.
Rather than conducting a transparent investigation into these deaths, the professional community appeared to circle the wagons. When some medical examiners attempted to discuss potential links between cardiac incidents and vaccination, they were often silenced by peers who labeled the inquiries as "misinformation." Dr. William Oliver, a dissenting voice in these threads, urged his colleagues to "examine evidence rather than attack people presenting disputed claims," noting that it was far too early to be "dogmatic" about the safety data.
Official Responses and Institutional Justification
The institutional response to these revelations has been characterized by a defensive adherence to the concept of "vaccine confidence." Public health officials have long maintained that any public discussion of potential risks could lead to "vaccine hesitancy," thereby endangering public health goals.
However, critics argue that this paternalistic approach is fundamentally anti-scientific. By suppressing the warnings of experts like Dr. Szarfman and failing to modernize their surveillance tools, the FDA and CDC effectively turned the American public into an uncontrolled experiment.
When questioned about the failure to implement the corrective algorithm, officials have largely deflected, citing the complexity of data management during a crisis. Yet, the admission from the FDA’s own pharmacovigilance chief that the limitations were known as early as 2020 suggests that the failure was not a result of incompetence, but of policy. Statistician William DuMouchel, speaking to The BMJ, lamented the outcome, stating plainly, "If they had paid attention to Ana, they would have done better."
Implications: The Erosion of Public Trust
The implications of these findings extend far beyond the technical failure of an algorithm. We are witnessing a fundamental rupture in the social contract between the state and the citizenry. The "safety first" mandate of the FDA and the "science-driven" promise of the CDC were, according to these documents, subordinated to a broader administrative goal of maintaining an unchallenged narrative.
Attorney Sujata Gibson, who has been instrumental in analyzing the medical examiner correspondence, argues that the documents reveal a deliberate strategy to "sweep evidence under the rug" when it didn’t fit the approved messaging. For the families of those who died shortly after vaccination, these revelations are more than just a bureaucratic failure—they are a betrayal of the transparency required of a free society.
As of late 2026, there is mounting pressure on Congress to launch a formal investigation into why career scientists were silenced and why the public was denied access to the limitations of the safety surveillance systems. Whether these revelations will lead to meaningful reform of the federal pharmacovigilance process or simply disappear into the annals of pandemic-era controversies remains to be seen.
One thing, however, is clear: the claim that the mRNA vaccine rollout was the most scrutinized in history has been dealt a massive, potentially fatal, blow. The "true clinical trial" occurred in real time, and the architects of that trial chose to mute the alarms.
Sources:
- The BMJ: "US Officials Suppressed Warnings Over Flawed COVID Vaccine Safety Algorithm" (2026)
- Children’s Health Defense: "NYC Medical Examiners Debated COVID Vaccine Safety: Emails Reveal"
- U.S. Senate Committee Records on Health and Human Services Oversight
